Wikipedia -WSS

Wikipedia

author：fashion 2025-09-30 11:07:10 - browse：383

A sign of pharmaceutical company Bayer in front of a blossomed tree — coverage from STAT — INA FASSBENDER/AFP via Getty Images

More hopeful news on the menopause front: Bayer announced on Monday encouraging results in two Phase 3 trials for its non-hormonal drug candidate, elinzanetant, meant to treat hot flashes. The results follow the recent market launch of Veozah, Astellas Pharma’s groundbreaking non-hormonal treatment for hot flashes, which was approved by the U.S. Food and Drug Administration last spring and received approval in the U.K., under the name Veozah, in December.

Elinzanetant is a neurokinin-1 and 3 receptor antagonist, and works by calming down the estrogen receptors in the brain that become hyperactive around menopause, causing hot flashes. The drug, a pill administered once a day, was shown to reduce both the frequency and intensity of hot flashes, and also met the secondary endpoints for improving sleep and quality of life, according to JoAnn Pinkerton, professor of obstetrics and gynecology and director of the Midlife Health at UVA Health, who is a clinical investigator for Bayer’s drug candidate.

Pinkerton said she was excited to see the broader quality of life improvements through elinzanetant: “Women have more than just hot flashes — it’s actually more about hot flushes, sweats, fatigue, lack of sleep and some of the mood changes that go on during [menopause].”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

WSS

Intellia plays down concerns on accidental germline transmission

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Ascension's ugly legal battle over care for poor patients in Texas

CDC says it’s too soon to assess risk posed by Covid subvariant

Ascension's ugly legal battle over care for poor patients in Texas

Study suggests new cause of Down syndrome: cells linked to aging

knowledge

Wikipedia

entertainment

The high cost of giving birth even with insurance

Profiling embryos to choose those with higher IQs is almost a reality

Medicare details structure of new drug price negotiation program

Arena BioWorks launches in Cambridge to speed drug discovery

Hepatitis C has a cure — but many Americans still lack access to it

Listen: Vivek Ramaswamy's star turn & leaky drug data

Medical leaders decry Supreme Court decision on affirmative action

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

United colonoscopy coverage change 'may cost lives,' doctors say

Kellogg’s is going to war over Mexico’s nutrition label rules

hotspot

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Life science postdocs should get big pay hike, NIH panel says

Can U.S. cancer drug shortages be fixed?

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Life science postdocs should get big pay hike, NIH panel says

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Wikipedia

entertainment

hotspot

Wikipedia